RMD vs. SNN: ResMed vs. Smith & Nephew Stock Comparison

November 11, 2026

How do ResMed (RMD) and Smith & Nephew (SNN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

ResMed (RMD) and Smith & Nephew (SNN) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

ResMed (RMD) trades as ordinary local shares, while Smith & Nephew (SNN) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for ResMed (RMD) and Smith & Nephew (SNN)
Profile Item	RMD	SNN
Name	ResMed Inc.	Smith & Nephew plc Sponsored ADR
Country/Region	United States	United Kingdom
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Equipment
Market Capitalization	33.10 billion USD	13.04 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	June 2, 1995	November 16, 1999
Security Type	Common Stock	ADR

Price Performance

Cumulative Growth

RMD

SNN

GSPC

ResMed (RMD) vs. Smith & Nephew (SNN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for ResMed (RMD) and Smith & Nephew (SNN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for ResMed (RMD) and Smith & Nephew (SNN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
Total Return (1Y)	-5.42%	-4.20%
Total Return (3Y, Annualized)	18.99%	11.34%
Total Return (5Y, Annualized)	-1.23%	-0.34%

Risk Profile

Drawdown History

RMD

SNN

GSPC

ResMed (RMD) vs. Smith & Nephew (SNN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for ResMed (RMD) and Smith & Nephew (SNN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
Volatility (1Y, Annualized)	30.80%	27.31%
Beta (5Y)	0.75	0.49
Max Drawdown (5Y)	-49.04%	-38.80%
Avg. Volume (3M)	1.32M	1.49M

Risk-Adjusted Performance

Risk-Return Positioning

RMD and SNN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
Sharpe Ratio (1Y)	-0.31	-0.31
Sortino Ratio (1Y)	-0.43	-0.46

Profitability

ROE (TTM)

ResMed (RMD) at 26.40% sits in the top ROE quartile, while Smith & Nephew (SNN) at 11.85% is closer to the peer norm — stronger capital efficiency for RMD.

RMD

Health Care Equipment & Services industry group

26.40%

Max: 47.61%
RMD: 26.40%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

SNN

Health Care Equipment & Services industry group

11.85%

Max: 47.61%
Q3: 14.36%
SNN: 11.85%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both ResMed (RMD) at 27.79% and Smith & Nephew (SNN) at 10.08% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

RMD

Health Care Equipment & Services industry group

27.79%

Max: 29.35%
RMD: 27.79%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

SNN

Health Care Equipment & Services industry group

10.08%

Max: 29.35%
SNN: 10.08%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Both ResMed (RMD) at 34.82% and Smith & Nephew (SNN) at 14.47% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

RMD

Health Care Equipment & Services industry group

34.82%

Max: 35.43%
RMD: 34.82%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

SNN

Health Care Equipment & Services industry group

14.47%

Max: 35.43%
SNN: 14.47%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
ROE (TTM)	26.40%	11.85%
ROA (TTM)	14.76%	5.16%
Net Margin (TTM)	27.79%	10.08%
Operating Margin (TTM)	34.82%	14.47%
Gross Margin (TTM)	61.77%	68.44%

Growth

Revenue Growth

Both ResMed (RMD) at 9.85% and Smith & Nephew (SNN) at 6.09% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Smith & Nephew (SNN) reports EPS growth of 52.34%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
Revenue Growth (YoY)	9.85%	6.09%
Revenue Growth (3Y CAGR)	10.21%	5.73%
EPS Growth (YoY)	--	52.34%
EPS Growth (3Y CAGR)	19.64%	42.01%

Financial Strength

Current Ratio (MRQ)

Both ResMed (RMD) at 2.65 and Smith & Nephew (SNN) at 2.14 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

RMD

Health Care Equipment & Services industry group

2.65

Max: 7.59
Q3: 4.00
RMD: 2.65
Median: 1.98
Q1: 1.37
Min: 0.30

SNN

Health Care Equipment & Services industry group

2.14

Max: 7.59
Q3: 4.00
SNN: 2.14
Median: 1.98
Q1: 1.37
Min: 0.30

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

ResMed (RMD) at 0.10 keeps leverage in the lower industry quartile, while Smith & Nephew (SNN) at 0.73 runs a more typical debt-to-equity mix.

RMD

Health Care Equipment & Services industry group

0.10

Max: 1.88
Q3: 0.91
Median: 0.58
Q1: 0.16
RMD: 0.10
Min: 0.00

SNN

Health Care Equipment & Services industry group

0.73

Max: 1.88
Q3: 0.91
SNN: 0.73
Median: 0.58
Q1: 0.16
Min: 0.00

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
Current Ratio (MRQ)	2.65	2.14
Debt / Equity (MRQ)	0.10	0.73
Net Debt / EBITDA	-0.19	2.19

Dividends

Dividend Yield (TTM)

Both ResMed (RMD) at 1.03% and Smith & Nephew (SNN) at 1.24% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

RMD

Health Care Equipment & Services industry group

1.03%

RMD: 1.03%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SNN

Health Care Equipment & Services industry group

1.24%

SNN: 1.24%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Both ResMed (RMD) at 22.40% and Smith & Nephew (SNN) at 53.20% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

RMD

Health Care Equipment & Services industry group

22.40%

RMD: 22.40%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SNN

Health Care Equipment & Services industry group

53.20%

SNN: 53.20%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
Dividend Yield (TTM)	1.03%	1.24%
Dividend Payout Ratio (TTM)	22.40%	53.20%

Valuation

P/E Ratio (TTM)

Both ResMed (RMD) at 21.43 and Smith & Nephew (SNN) at 21.19 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

RMD

Health Care Equipment & Services industry group

21.43

Max: 80.41
Q3: 47.62
Median: 29.93
RMD: 21.43
Q1: 21.19
Min: 4.21

SNN

Health Care Equipment & Services industry group

21.19

Max: 80.41
Q3: 47.62
Median: 29.93
SNN: 21.19
Q1: 21.19
Min: 4.21

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

Smith & Nephew (SNN) at 2.07 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.

RMD

Health Care Equipment & Services industry group

5.77

Max: 8.80
RMD: 5.77
Q3: 4.32
Median: 2.13
Q1: 1.10
Min: 0.03

SNN

Health Care Equipment & Services industry group

2.07

Max: 8.80
Q3: 4.32
Median: 2.13
SNN: 2.07
Q1: 1.10
Min: 0.03

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

ResMed (RMD) at 5.56 sits near its industry’s typical P/B ratio, while Smith & Nephew (SNN) at 12.80 prices above its benchmark range — SNN looks rich relative to book.

RMD

Health Care Equipment & Services industry group

5.56

Max: 11.68
Q3: 6.12
RMD: 5.56
Median: 3.00
Q1: 1.73
Min: -1.31

SNN

Health Care Equipment & Services industry group

12.80

SNN: 12.80
Max: 11.68
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31

ResMed (RMD) vs. Smith & Nephew (SNN): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for ResMed (RMD) and Smith & Nephew (SNN)
Metric	RMD	SNN
P/E Ratio (TTM)	21.43	21.19
P/S Ratio (TTM)	5.77	2.07
P/B Ratio (MRQ)	5.56	12.80
Free Cash Flow Yield (TTM)	3.92%	8.12%